search
US Biological
Trends
- 1Fruitless gene discovery could stop mosquitoes from mating▼Study finds exploiting ‘fruitless’ gene could stop mating mosquitoes
A new study reports that targeting the 'fruitless' gene, which governs mating behaviour, could prevent mosquitoes from reproducing. Researchers suggest manipulating the gene may block courtship and mating, offering a potential method to suppress disease-carrying mosquito populations without pesticides. The findings are being widely reported across US news outlets, drawing interest for possible applications in malaria and dengue control.
- 2Salsa bottle delivered to life science lab●# HappyFriday Delivered today🤩 Salsa from US Biological 🧪🌶️ It used to be graded as “Molecular Biologist Grade” scientis
US Biological, a laboratory supplies company, delivered an order of salsa to a scientist, who noted the product is graded as "Molecular Biologist Grade". The playful contrast between a lab reagent supplier and snack food prompted light-hearted comments among science workers sharing in-jokes about laboratory life.
- 3Colorado ballot measure would restrict sports teams by biological sex▼Colorado ballot measure looks to require sports teams based off biological sex only
A proposed ballot measure in Colorado seeks to require that sports teams in the state be designated based on biological sex only, a move that would affect transgender athletes' participation. The initiative adds Colorado to the list of US states where the question of transgender athletes in school and recreational sports has become a live political and legal debate.
- 4Biosimilars user fee program seen as boost for competition▼How the biosimilars user fee program supports competition and patients
PhRMA is highlighting how the biosimilars user fee program, under which the FDA collects fees from companies to help fund review of biosimilar products, supports competition and benefits patients. The industry group's framing suggests the program helps bring lower-cost alternatives to expensive biologic medicines to market, expanding treatment options and reducing costs in the US pharmaceutical market.